A Phase 2 Study Of Titrating-Dose Lonafarnib Plus Ritonavir In Patients With Chronic Hepatitis D: Interim Results From The Lonafarnib With Ritonavir In HDV-4 (LOWR HDV-4) Study

作者:Wedemeyer Heiner; Port Kerstin; Deterding Katja; Wranke Anika; Kirschner Janina; Martins Eduardo B; Glenn Jeffrey; Cornberg Markus; Manns Michael P
来源:67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), 2016-11-11 to 2016-11-15.
  • 出版日期2016-10